| |
|
| |
| |
|
|
 |
| |
|
|
| |
Fact sheet about HIV/AIDS in Nigeria |
|
| |
| |
|
|
|
| |
| Latest Statistics on HIV/AIDS in Nigeria released |
Updated: Jan 2006 |
Population: |
127 million |
HIV Prevalence Rate (%): |
5.6 |
No. Of People living with HIV/AIDS: |
6.1 million |
No. Of People in need of ART: |
540,000 |
No. Of People Currently On ART (October 2005): |
17,000 |
| No. Of People on ART Public Sector: |
11,435 |
| No. Of People on ART in Non Govt Programmes |
6,565 (3000 Ranbaxy Private Company) (3000 undefined) |
|
No. Of People Exptd to be on ART (End of 2005): |
15,000 |
Front Line Drug Regimen: |
Zidovudine+Lamivudine+Nevirapine |
Treatment Sites: |
27 |
Global Fund 2 Year Approved Funding
(Round 1: 1 January 2004):
Total Funds Disbursed By The Global Fund: |
US$ 8,708,684.00 |
Total Funds Disbursed By The World Bank
Multi-Country HIV/AIDS Programme (MAP): |
US$90.3 million |
Total Funds Disbursed By PEPFAR: |
US$ 55.5 million |
|
| |
| |
| |
| Compare with situation in South Africa |
| |
| Treatment Map: South Africa |
Updated: Oct 2005 |
Population: |
45.2 million |
HIV Prevalence Rate (%) 2003 End: |
29.5 |
No. Of People living with HIV/AIDS: |
5.3 million |
No. Of People in need of ART: |
840,000 |
No. Of People Currently On ART (Sep 04): |
104,000 |
No. Of People on ART Public Sector:
No. Of People on ART in Non Govt Programmes |
62,000 |
No. Of People Exptd to be on ART (2005 End): |
200,000 |
Front Line Drug Regimen: |
Zidovudine+Didanosine+Ritonavir
Stavudine+Lamivudine+Efavirenz
Stavudine+lamivudine+Nevirapine |
Treatment Sites: |
178 |
Global Fund 2 Year Approved Funding
(Round 3: Sept 2004):
Total Funds Disbursed By The Global Fund: |
US$15.5 million |
Total Funds Disbursed By The World Bank
Multi-Country HIV/AIDS Programme (MAP): |
Nil |
Total Funds Disbursed By PEPFAR: |
US$105 785 630.00 |
|
| |
| Source: Nigeria Ministry of Health NAC, UNAIDS, The Global Fund, The World Bank, US State Department |
|
|
|
| |
|
|
|
| |
| |
|
| |
|
|
Copyright © 2006 :: NigeriaHIVinfo.com :: All rights reserved |
|
|
|
|
